Trials / Not Yet Recruiting

Not Yet RecruitingNCT06828705

Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride Camera

Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride (CZT) Camera (VERITON-CT)

Status: Not Yet Recruiting
Phase: —
Study type: Observational
Enrollment: 300 (estimated)

Sponsor: Central Hospital, Nancy, France · Academic / Other
Sex: All
Age: 18 Years – 99 Years
Healthy volunteers: Not accepted

Summary

Detailed description

Datscan scintigraphy is a nuclear medicine examination allowing the diagnosis of neurodegenerative pathologies linked to damage to dopaminergic pathways, such as Parkinson's disease (essential for the differential diagnosis of essential tremor). There are several types of cameras allowing its performance: * Conventional Anger cameras and, * CZT (Cadmium-Zinc-Telluride) semiconductor cameras. At the Nancy University Hospital, the nuclear medicine department has a wide-field Cadmium-Zinc-Telluride camera: VERITON-CT (Spectrum Dynamics). The interpretation of this examination is purely visual. The objectives are therefore to: * Create the first international database of semi-quantitative values in 3D scintigraphy with Datscan performed with a VERITON-CT camera. * Compare this database with another database from a conventional Anger camera (Lyon Nuclear Medicine Department) to show its superiority.

Conditions

Neurodegenerative Diseases

Interventions

Type	Name	Description
OTHER	datscan scintigraphy	Semi-quantitative analysis on Datscan imaging scintigraphy

Timeline

Start date: 2025-07-30
Primary completion: 2025-08-15
Completion: 2025-11-30
First posted: 2025-02-14
Last updated: 2025-07-22

Source: ClinicalTrials.gov record NCT06828705. Inclusion in this directory is not an endorsement.